Viewing Study NCT03006302

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2026-02-26 @ 1:10 AM
Study NCT ID: NCT03006302
Status: COMPLETED
Last Update Posted: 2024-10-08
First Post: 2016-12-28
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Pancreatic Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pancreatic cancer View
None Vaccine View
None Immunotherapy View
None Pembrolizumab View
None PD-1 View
None IDO View
None CRS-207 View
None Epacadostat View